Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy

NCT04800978 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
37
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Samsung Medical Center

Collaborators